A pan-cancer analysis of CTSC as a candidate prognostic and immune-related biomarker
Our study underscores the multifaceted role of CTSC in tumor immunity and progression, supporting its potential as a prognostic biomarker and therapeutic target across cancer types. These findings provide a foundation for further mechanistic and clinical investigation into CTSC-targeted strategies.
Authors
- Dehua Gong (ORCID: https://orcid.org/0000-0002-8434-8172)
- Lan Zheng (ORCID: https://orcid.org/0009-0007-3326-6656)
- Peng Chen (ORCID: https://orcid.org/0000-0002-8484-9356)
- Xin Liu (ORCID: https://orcid.org/0000-0003-4094-1211)
- Xing Wei (ORCID: https://orcid.org/0000-0002-3035-5633)
- Jinwen Cai
- Bin Ge (ORCID: https://orcid.org/0000-0002-1491-2364)
- Yiling Xi
Institutions
- Chongqing University (CN)
- Chengdu Medical College (CN)
- Huzhou Vocational and Technical College (CN)
- Wuhou District People's Hospital, Chengdu (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
- Chongqing Municipal Government (CN)
- Chongqing Three Gorges University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s12672-025-04124-4
- Primary Topic
- Bone and Dental Protein Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00